Press news Biocartis Group NV: Results of the Extraordinary Shareholders’ Meeting held on 2 September 2020

NEXT STORY
AB Science: New independent research reveals that masitinib has direct anti-viral activity against the SARS-CoV-2 virus in vitro and is a promising candidate for treating COVID-19
PREV STORY
“My Disease May Be Invisible, But I’m Not”: Patients Tell Their Stories During September’s Rheumatic Disease Awareness Month
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Combat Helmet Market Size Worth USD 3.32 Billion by 2027 at 5.2% CAGR – Report by Market Research Future (MRFR)

author_avatar
NASDAQ Market News

Increasing Demand And Development For Next Generation Biologics In The Pharmaceuticals Market 2020

author_avatar
NASDAQ Market News

NICE publishes advice on gammaCore for the treatment of cluster headache in the UK

Report contributors agreed gammaCore was highly innovative, may be more effective than standard of ...

author_avatar
NASDAQ Market News